Exploration of crystal structure, supramolecular organization, and computational studies of a novel pyrazole derivative: A structural and theoretical perspectives

An eminent challenge in contemporary medicine and pharmacy is the identification of powerful, biologically active, and benign anti-COVID drugs. The objective of this work is to synthesize 3-chloro-1-(3-chloropyridin-2yl)-1H-pyrazole-5-carboxylic acid to investigate its properties using different spectroscopic methods. The crystal structure of the compound is determined using single-crystal X-ray diffraction methodology. Hirshfeld surface analysis was employed to evaluate the impact of intermolecular interactions on crystal packing. The interactions were visually depicted using 2D fingerprint plots, which highlighted the specific surface area associated with each interactant. Indications suggest that the crystal packing is mostly governed by C-H...O and N-H...O interactions, resulting in the formation of S(7) self-motif and R44(24) synthon, which greatly improve crystal stability. Density functional theory (DFT) was employed to better examine the structural and electrical characteristics. Computations were conducted at the 6-311+G(d,p) level to determine the optimal geometry, total energy, HOMO-LUMO gap, and vibrational spectra. The results showed a HOMO-LUMO gap of 3.092 eV, suggesting a moderate amount of stability. Bader et al. employed reduced density gradient (RDG) techniques and topological analysis, taking into account the quantum theory of atoms in molecules (QTAIM), to examine noncovalent interactions. Additionally, the molecule satisfies Lipinski's rule of five and exhibits encouraging pharmacokinetic activities. Additional in-silico investigations, including molecular docking, were conducted on the SARS-CoV-2 spike protein variation to assist in the advancement of enhanced vaccines and therapeutics.